People: Celsion Corp (CLSN.W)

CLSN.W on CBOE When Trading NASDAQ Global Select Market

0.95USD
14 May 2013
Price Change (% chg)

$0.01 (+1.09%)
Prev Close
$0.94
Open
$0.95
Day's High
$0.95
Day's Low
$0.95
Volume
200
Avg. Vol
2,631
52-wk High
$9.37
52-wk Low
$0.75

Search Stocks

Church, Jeffrey 

Brief Biography

Mr. Jeffrey W. Church is Senior Vice President - Corporate Strategy and Investor Relations of Celsion Corporation since July 8, 2011. Mr. Church joined Celsion in July 2010 as Vice President, Chief Financial Officer and Corporate Secretary. Immediately prior to joining Celsion, Mr. Church served as Chief Financial Officer and Corporate Secretary of Alba Therapeutics Corporation, a privately held life science company from 2007 until 2010. From 2006 until 2007, he served as Vice President, CFO and Corporate Secretary for Novavax, Inc., a publicly traded vaccine development company. From 1998 until 2006, he served as Vice President, CFO and Corporate Secretary for GenVec, Inc., a publicly traded life science and biotechnology company. Prior to that, he held senior financial positions at BioSpherics Corporation and Meridian Medical Technologies, both publicly traded companies. He started his career with Price Waterhouse from 1979 until 1986. Mr. Church holds a B.S. degree in accounting from the University of Maryland and is a Certified Public Accountant.

Basic Compensation

Total Annual Compensation, USD Long-Term Incentive Plans, USD All Other, USD Fiscal Year Total, USD
301,664 -- 128,137 454,701

Options Compensation

  Quantity Market Value
Excercisable -- --
Unexercisable -- --
Excercised -- --
Name Fiscal Year Total

Max Link

--

Michael Tardugno

875,216

Gregory Weaver

581,293

Jeffrey Church

454,701

Nicholas Borys

510,776

Pok Yu Chow

--
As Of 30 Dec 2011
Search Stocks